Having validated the consistent upregulation of FRZB in muscle lysates of ALS and to a lesser extent non-ALS neurogenic disease, we performed immunohistochemistry to determine its location in muscle. This evidence concerns the gene FRZB and amyotrophic lateral sclerosis.